Royal Marsden NHS Foundation Trust: Lymphoma trials

The registry lists 10 Lymphoma studies with Royal Marsden NHS Foundation Trust as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 2 3No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• CLIMB: CNS Lymphoma Imaging and Molecular Biomarkers StudyRecruitingNCT05828628
• Breast-implant ASsocIated anaplastIc Large Cell Lymphoma and CApsular ContractureStatus unknownNCT05017337
• Blood Immunophenotyping in Staging of Indolent B-cell Lymphomas V1.0Status unknownNCT03265158
• Tissue Collection for Biomarkers Determining Resistance to IbrutinibStatus unknownNCT02267590
• Phase II Study Comparing LR-GEM to R-GEM-P in Second-line Treatment of Diffuse Large B-cell Lymphoma (LEGEND)Status unknownNCT02060656Phase 2
• CHOP vs GEM-P in 1st Line Treatment of T-cell Lymphoma, Multicentre Phase II StudyStatus unknownNCT01719835Phase 2
• R-CHOP-B Bevacizumab for Diffuse Large B Cell LymphomaTerminatedNCT00788606Phase 2
• A Retrospective Study of Toxicity and Outcome of High Dose Chemotherapy With Autologous Stem Cell Transplant in Patients With Hodgkin Lymphoma (HL).CompletedNCT00301314
• A Retrospective Review of Gemcitabine, Methylprednisolone Cisplatin (GEM-P) With or Without Rituximab in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)CompletedNCT00301301
• Dual Time Point PET Imaging in LymphomaStatus unknownNCT00297557